top of page
Latest News
Search
Equitable Access to Long-Acting HIV Treatment
ADAP coverage gaps for long-acting injectable HIV treatments and equity implications.
Travis Roppolo
Jun 2, 20248 min read
Breakthroughs in HIV Research from CROI 2024
Major HIV research breakthroughs from CROI 2024: long-acting treatments and prevention advances.
Travis Roppolo
Mar 24, 20247 min read
Cabenuva Approved for 2 Month Injections; Insurers Remain a Barrier to Access
FDA extends Cabenuva to 2-month injections but insurance barriers continue to restrict patient access.
Jen Laws
Feb 13, 20224 min read
The Future is Now: Welcome to the Age of Injectables
FDA approves Cabenuva, first long-acting injectable HIV regimen offering monthly alternative to daily pills.
Jen Laws
Feb 7, 20213 min read
We Need Your Support Today!
bottom of page